SOP Guide for Pharma

API Manufacturing: SOP for Reporting Deviations in IPC Parameters – V 2.0

API Manufacturing: SOP for Reporting Deviations in IPC Parameters – V 2.0

Standard Operating Procedure for Reporting Deviations in IPC Parameters in API Manufacturing

Department API Manufacturing
SOP No. SOP/API/115/2025
Supersedes SOP/API/115/2022
Page No. Page 1 of 10
Issue Date 13/04/2025
Effective Date 15/04/2025
Review Date 13/04/2026

1. Purpose

To outline the procedure for identifying, documenting, evaluating, and reporting deviations in In-Process Control (IPC) parameters observed during API manufacturing, ensuring appropriate actions are taken to prevent recurrence and maintain compliance with cGMP requirements.

2. Scope

This SOP is applicable to all IPC parameters monitored during API manufacturing at each process stage, including but not limited to

pH, temperature, LOD, reaction time, and assay values. It includes initial detection, documentation, investigation, and resolution.

3. Responsibilities

  • Production Chemist: Immediately report any deviation in IPC parameters, document initial observations, and stop further processing if required.
  • QC Analyst: Verify parameter results and assist in evaluation of deviation cause.
  • QA Officer: Log the deviation, initiate investigation, ensure impact assessment, and recommend CAPA if needed.

4. Accountability

The QA Head is accountable for ensuring deviation reporting, tracking, closure, and trend analysis. The Production Head is accountable for initiating immediate action in the event of any IPC deviation.

5. Procedure

5.1 Identification of IPC Deviations

  1. During IPC checks, if any parameter is found outside the established acceptance criteria:
    • Immediately stop further processing of the affected batch stage.
    • Mark the equipment status as “ON HOLD.”
  2. Document the deviation in the batch manufacturing record and notify QA and the production supervisor without delay.

5.2 Documentation and Notification

  1. Record the following in the IPC Deviation Reporting Form (Annexure-1):
    • Batch No., Stage, Date & Time
    • Parameter and Observed Value
    • Expected Range
    • Instrument used and person reporting
  2. QA shall assign a deviation number and initiate preliminary assessment.

5.3 Investigation and Evaluation

  1. QA along with production and QC shall:
    • Conduct a root cause analysis (RCA)
    • Determine whether the deviation is minor, major, or critical
    • Evaluate the impact on product quality and other batches, if applicable
  2. QA shall document findings in the deviation section of the IPC logbook and update the Deviation Register.

5.4 Corrective and Preventive Action (CAPA)

  1. If required, CAPA shall be initiated to:
    • Correct the current issue (corrective action)
    • Prevent recurrence in future batches (preventive action)
  2. QA shall track CAPA implementation and assess effectiveness.
  3. All CAPAs shall be recorded in the CAPA Log and linked with the deviation report.

5.5 Deviation Closure

  1. QA shall ensure that:
    • All investigations are complete
    • Impact assessment is documented
    • CAPAs are implemented and verified
  2. Deviation shall be closed formally in the Deviation Register, signed by QA Head.

5.6 Trending and Review

  1. QA shall conduct monthly/quarterly review of IPC deviations to:
    • Identify recurrence patterns
    • Assess system gaps or training needs
    • Improve processes accordingly
  2. Deviations trending report shall be shared during management reviews.

6. Abbreviations

  • IPC: In-Process Control
  • SOP: Standard Operating Procedure
  • QA: Quality Assurance
  • QC: Quality Control
  • RCA: Root Cause Analysis
  • CAPA: Corrective and Preventive Action

7. Documents

  1. IPC Deviation Reporting Form (Annexure-1)
  2. Deviation Register
  3. CAPA Log
  4. BMR (Batch Manufacturing Record)

8. References

  • ICH Q10 – Pharmaceutical Quality System
  • 21 CFR Part 211 – cGMP for Finished Pharmaceuticals
  • WHO TRS 986 – GMP Guidelines

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: IPC Deviation Reporting Form

Date Batch No. Parameter Observed Value Expected Range Stage Reported By Remarks
13/04/2025 API-20250413 pH 4.1 5.0–6.0 Post-Reaction Ravi Kumar Deviation Logged

Revision History:

Revision Date Revision No. Details Reason Approved By
01/01/2022 1.0 Initial SOP Release Compliance Requirement QA Head
13/04/2025 2.0 Expanded CAPA and trending sections Regulatory Audit Observation QA Head
Exit mobile version